1. O-L07 Role of liver resection for metastases from uveal melanoma: Experience from a supra-regional centre, current evidence, and future prospects. (16th December 2021) Authors: Trivedi, Dharmadev; Aldulaimi, Natasha; Karydis, Ioannis; Wheater, Matthew; Modi, Sachin; Stedman, Brian; Karavias, Dimitrios; Primrose, John; Pearce, Neil; Takhar, Arjun Journal: British journal of surgery Issue: Volume 108:Supplement 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma. Issue 2 (25th January 2022) Authors: Modi, Sachin; Gibson, Tom; Vigneswaran, Ganesh; Patel, Shian; Wheater, Matthew; Karydis, Ioannis; Gupta, Sanjay; Takhar, Arjun; Pearce, Neil; Ottensmeier, Christian; Stedman, Brian Journal: Melanoma research Issue: Volume 32:Issue 2(2022) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Liver resection for metastatic uveal melanoma: experience from a supra-regional centre and review of literature. Issue 1 (21st November 2022) Authors: Trivedi, Dharmadev B.; Aldulaimi, Natasha; Karydis, Ioannis; Wheater, Matthew; Modi, Sachin; Stedman, Brian; Karavias, Dimitrios; Primrose, John; Pearce, Neil; Takhar, Arjun S. Journal: Melanoma research Issue: Volume 33:Issue 1(2023) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma. (3rd May 2016) Authors: Karydis, Ioannis; Chan, Pui Ying; Wheater, Matthew; Arriola, Edurne; Szlosarek, Peter W.; Ottensmeier, Christian H. Journal: Oncoimmunology Issue: Volume 5:Number 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First‐Line Therapy for Extensive‐Stage SCLC. Issue 9 (September 2016) Authors: Arriola, Edurne; Wheater, Matthew; Galea, Ian; Cross, Nadia; Maishman, Tom; Hamid, Debbie; Stanton, Louise; Cave, Judith; Geldart, Tom; Mulatero, Clive; Potter, Vannessa; Danson, Sarah; Woll, Pennella J.; Griffiths, Richard; Nolan, Luke; Ottensmeier, Christian Journal: Journal of thoracic oncology Issue: Volume 11:Issue 9(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients. Issue 5 (October 2015) Authors: Ahmad, Saif S.; Qian, Wendi; Ellis, Sarah; Mason, Elaine; Khattak, Muhammad A.; Gupta, Avinash; Shaw, Heather; Quinton, Amy; Kovarikova, Jarmila; Thillai, Kiruthikah; Rao, Ankit; Board, Ruth; Nobes, Jenny; Dalgleish, Angus; Grumett, Simon; Maraveyas, Anthony; Danson, Sarah; Talbot, Toby; Harries,... Journal: Melanoma research Issue: Volume 25:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis. (1st September 2016) Authors: Arriola, Edurne; Wheater, Matthew; Lopez, Maria Antonette; Thomas, Gareth; Ottensmeier, Christian Journal: Oncoimmunology Issue: Volume 5:Number 9(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ipilimumab in the real world. Issue 5 (October 2015) Authors: Ahmad, Saif S.; Qian, Wendi; Ellis, Sarah; Mason, Elaine; Khattak, Muhammad A.; Gupta, Avinash; Shaw, Heather; Quinton, Amy; Kovarikova, Jarmila; Thillai, Kiruthikah; Rao, Ankit; Board, Ruth; Nobes, Jenny; Dalgleish, Angus; Grumett, Simon; Maraveyas, Anthony; Danson, Sarah; Talbot, Toby; Harries,... Journal: Melanoma research Issue: Volume 25:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023) Authors: Brown, Janet E; Royle, Kara-Louise; Gregory, Walter; Ralph, Christy; Maraveyas, Anthony; Din, Omar; Eisen, Timothy; Nathan, Paul; Powles, Tom; Griffiths, Richard; Jones, Robert; Vasudev, Naveen; Wheater, Matthew; Hamid, Abdel; Waddell, Tom; McMenemin, Rhona; Patel, Poulam; Larkin, James; Faust, G... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis. Issue 1 (30th January 2018) Authors: Oke, Anuoluwapo R; Wheater, Matthew; Karydis, Ioannis; Wallis, Dinny Journal: Rheumatology advances in practice Issue: Volume 2:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗